Related references
Note: Only part of the references are listed.Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice
Frederique Yiannikouris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
Giuliano Tocci et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Angiotensin-Converting Enzyme 2 Deficiency in Whole Body or Bone Marrow-Derived Cells Increases Atherosclerosis in Low-Density Lipoprotein Receptor-/- Mice
Sean E. Thatcher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms
Jian-an Wang et al.
ATHEROSCLEROSIS (2011)
Side Chain-oxidized Oxysterols Regulate the Brain Renin-Angiotensin System through a Liver X Receptor-dependent Mechanism
Laura Mateos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Adipose Tissue-Specific Regulation of Angiotensinogen in Obese Humans and Mice: Impact of Nutritional Status and Adipocyte Hypertrophy
Shintaro Yasue et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic β-cells via angiotensin II type 2 receptors
Kwan Yi Chu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
Sergio Henrique S. Santos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
AT1 angiotensin II receptor and novel non-AT1, non-AT2 angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat
Erick A. Bourassa et al.
BRAIN RESEARCH (2010)
Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records
Yayoi Nishida et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells
Li Zhou et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
Sharell M. Bindom et al.
DIABETES (2010)
Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance
Stefan Pscherer et al.
DIABETES CARE (2010)
Tissue-specific Pattern of Angiotensin-converting Enzyme 2 Expression in Rat Pancreas
H. J. Fang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity
Sadanori Okada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations
Jason D. Fowler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats
Jorge F. Giani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice
Lisa A. Cassis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Intrarenal Angiotensin III Infusion Induces Natriuresis and Angiotensin Type 2 Receptor Translocation in Wistar-Kyoto but not in Spontaneously Hypertensive Rats
Shetal H. Padia et al.
HYPERTENSION (2009)
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor
Sophie Van Linthout et al.
HYPERTENSION (2009)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
Michael Hecht Olsen et al.
JOURNAL OF HYPERTENSION (2009)
The sweeter side of ACE2: Physiological evidence for a role in diabetes
Sharell M. Bindom et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
The adipose renin-angiotensin system: Role in cardiovascular disease
Sean Thatcher et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Angiotensin II induces superoxide generation via NAD(P)H oxidase activation in isolated rat pancreatic islets
A. E. Hirata et al.
REGULATORY PEPTIDES (2009)
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
Manisha Gupte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Local adipose tissue renin-angiotensin system
Lisa A. Cassis et al.
CURRENT HYPERTENSION REPORTS (2008)
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity
Helmy M. Siragy et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats
Shetal H. Padia et al.
HYPERTENSION (2008)
Angiotensin II Upregulates Acyl-CoA:Cholesterol Acyltransferase-1 via the Angiotensin II Type 1 Receptor in Human Monocyte-Macrophages
Tomoko Kanome et al.
HYPERTENSION RESEARCH (2008)
The value of current interventions for obesity
Arya M. Sharma
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice
Ming-Jia Niu et al.
ENDOCRINE (2008)
Management of arterial hypertension in obese patients
Ulrich O. Wenzel et al.
CURRENT HYPERTENSION REPORTS (2007)
Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice:: the DO-IT prospective observational study
Klaus G. Parhofer et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Effect of telmisartan on cholesterol levels in patients with hypertension - Saga telmisartan aggressive research (STAR)
T. Inoue et al.
HORMONE AND METABOLIC RESEARCH (2007)
Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and β-cells
Galina Chipitsyna et al.
ENDOCRINOLOGY (2007)
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome:: A sub analysis of the Treat to Target post authorization survey.: Prospective observational, two armed study in 14,200 patients
Ulrich Kintscher et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Discrepancy between improvement of insulin sensitivity and that of arterial endothelial function in patients receiving antihypertensive medication
Hirofumi Tomiyama et al.
JOURNAL OF HYPERTENSION (2007)
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
Asterios Karagiannis et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome
Yoshihiko Ichikawa
INTERNAL MEDICINE (2007)
Comparative Effects of Telmisartan and Valsartan on Insulin Resistance in Hypertensive Patients with Metabolic Syndrome
Yoshihiko Ichikawa
INTERNAL MEDICINE (2007)
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment - A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Joshua I. Barzilay et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system
SH Ko et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets
R Lupi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients
KK Koh et al.
DIABETES CARE (2006)
Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats
AC Hakam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes
M Burnier et al.
JOURNAL OF HYPERTENSION (2006)
AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity
CM Boustany et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat
JA Sloniger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf et al.
DIABETOLOGIA (2005)
Weight loss and the renin-angiotensin-aldosterone system
S Engeli et al.
HYPERTENSION (2005)
Clinical evidence for drug treatments in obesity-associated hypertensive patients - A discussion paper
SA Doggrell
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2005)
Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats
AC Hakam et al.
HYPERTENSION (2005)
Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat
C Tikellis et al.
DIABETES (2004)
Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas
PF Wong et al.
REGULATORY PEPTIDES (2004)
Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients
L Prat-Larquemin et al.
OBESITY RESEARCH (2004)
Development of diabetes is retarded by ACE inhibition in hypertensive patients - a subanalysis of the Captopril Prevention Project (CAPPP)
A Niklason et al.
JOURNAL OF HYPERTENSION (2004)
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets
T Lau et al.
DIABETOLOGIA (2004)
Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice
TA Henriques et al.
ENDOCRINOLOGY (2004)
Hyperch olesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor
A Daugherty et al.
CIRCULATION (2004)
Is there a rationale for angiotensin blockade in the management of obesity hypertension?
AM Sharma
HYPERTENSION (2004)
Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity
K Rahmouni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension
CM Boustany et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Angiotensinogen localization and secretion in the rat pancreas
M Regoli et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study
G Grassi et al.
JOURNAL OF HYPERTENSION (2003)
Metabolic outcome during 1 year in newly detected hypertensives: Results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)
LH Lindholm et al.
JOURNAL OF HYPERTENSION (2003)
Changes of angiotensin-converting enzyme activity in the pancreas of chronic hypoxia and acute pancreatitis
SS Ip et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Enalapril reduces the incidence of diabetes in patients with chronic heart failure - Insight from the Studies of Left Ventricular Dysfunction (SOLVD)
E Vermes et al.
CIRCULATION (2003)
Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling
T Ogihara et al.
HYPERTENSION (2002)
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
LH Lindholm et al.
JOURNAL OF HYPERTENSION (2002)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Comparison of circulating and local adipose tissue reninangiotensin system in normotensive and hypertensive obese subjects
E Faloia et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat
I Hainault et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Ramipril and the development of diabetes
S Yusuf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Hyperglycemia modulates angiotensinogen gene expression
I Gabriely et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
I Golovchenko et al.
CIRCULATION RESEARCH (2000)
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells -: The potential role of transcription factor NF-κB
DY Li et al.
CIRCULATION (2000)
Increased adipose angiotensinogen gene expression in human obesity
V van Harmelen et al.
OBESITY RESEARCH (2000)
The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity
V van Harmelen et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Gene expression of angiotensinogen in adipose tissue of obese patients
G Giacchetti et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Development of hypertension in a rat model of diet-induced obesity
AD Dobrian et al.
HYPERTENSION (2000)
Share Paper
